New flu shot could change how we prevent illness
A new antiviral shot called CD388 could potentially make a significant impact this flu season based on trial results and expert opinion.
In a recent trial with over 5,000 participants aged 16 to 64, just one dose cut flu infections by 76% for up to six months.
CD388 mixes an existing antiviral with an antibody, giving long-lasting protection—no need to kickstart your immune system.
Shot protected against all major flu strains
Researchers tested three different doses and found even the lowest worked pretty well.
The shot protected against all major flu strains and didn't raise any big safety concerns.
It's especially promising for people whose bodies don't respond well to regular vaccines.
CD388 could ease pressure on healthcare workers
With experts warning of a tough flu season ahead—and thousands of deaths last year—CD388 could help keep more people out of hospitals and ease pressure on healthcare workers.
The FDA has even fast-tracked it as a "Breakthrough Therapy," so it might be available sooner than you'd think.